Cargando…

Do we still need renal biopsy in lupus nephritis?

The natural course of systemic lupus erythematosus (SLE) is characterized by periods of disease activity and remissions. Prolonged disease activity results in cumulative organ damage. Lupus nephritis is one of the most common and devastating manifestations of SLE. In the era of changing therapy to l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haładyj, Ewa, Cervera, Ricard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie 2016
Materias:	Review Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918045/ https://www.ncbi.nlm.nih.gov/pubmed/27407281 http://dx.doi.org/10.5114/reum.2016.60214

Ejemplares similares

Repeat renal biopsy in lupus nephritis – unnecessary harm and risk of complications or important diagnostic tool with clinical consequences?
por: Haładyj, Ewa, et al.
Publicado: (2016)

Anti-glomerular basement membrane nephritis: why we still ‘need’ the kidney biopsy
por: Bomback, Andrew S.
Publicado: (2012)

Kidney biopsy in lupus nephritis after achieving clinical renal remission: paving the way for renal outcome assessment
por: Lledó-Ibáñez, Gema Maria, et al.
Publicado: (2022)

Role of early repeated renal biopsies in lupus nephritis
por: Zickert, A, et al.
Publicado: (2014)

Do we still need supertrees?
por: Haeseler, Arndt von
Publicado: (2012)

Renal Fibrosis in Lupus Nephritis
por: Sciascia, Savino, et al.
Publicado: (2022)

The Role of PLA2R in Primary Membranous Nephropathy: Do We Still Need a Kidney Biopsy?
por: McDonnell, Thomas, et al.
Publicado: (2023)

Revisiting Vasculopathy in Lupus Nephritis: A Renal Biopsy Evaluation Study
por: Lakshmi, V Ramya, et al.
Publicado: (2022)

Renal Mononuclear Phagocytes in Lupus Nephritis
por: Davidson, Anne
Publicado: (2021)

Renal microvascular lesions in lupus nephritis
por: Ding, Ying, et al.
Publicado: (2019)

Do we still need to do dual tracer localisation for sentinel node biopsy in patients with early breast cancer?
por: Najeeb, Erum, et al.
Publicado: (2021)

Prediction of prognosis and renal outcome in lupus nephritis
por: Parodis, Ioannis, et al.
Publicado: (2020)

Contribution of Clinically Indicated Repeat Renal Biopsy in Indian Patients with Lupus Nephritis
por: Gupta, Krishan L., et al.
Publicado: (2020)

The Spectrum of C4d Deposition in Renal Biopsies of Lupus Nephritis Patients
por: Ding, Ying, et al.
Publicado: (2021)

Value of repeat biopsy in lupus nephritis flares
por: Greloni, G, et al.
Publicado: (2014)

The value of repeat biopsy in lupus nephritis flares
por: Narváez, Javier, et al.
Publicado: (2017)

Opinion: PARP inhibitors in cancer—what do we still need to know?
por: Wicks, Andrew J., et al.
Publicado: (2022)

PRO: Do We Still Need Whole-Brain Irradiation for Brain Metastases?
por: Popp, Ilinca, et al.
Publicado: (2023)

Treat-to-Target in Lupus Nephritis. What is the Role of the Repeat Kidney Biopsy?
por: Parodis, Ioannis, et al.
Publicado: (2022)

Kidney Biopsy in Pregnant Women with Glomerular Diseases: Focus on Lupus Nephritis
por: Moroni, Gabriella, et al.
Publicado: (2023)

Do we need new autoantibodies in lupus?
por: Scofield, R Hal
Publicado: (2010)

The Value of a Panel of Autoantibodies for Predicting the Activity of Lupus Nephritis at Time of Renal Biopsy
por: Moroni, Gabriella, et al.
Publicado: (2015)

Multidisciplinary Lupus Nephritis Clinic Reduces Time to Renal Biopsy and Improves Care Quality
por: Garg, Shivani, et al.
Publicado: (2022)

Immunity and early atherosclerosis in the course of systemic lupus erythematosus, mixed connective tissue disease and antiphospholipid syndrome
por: Haładyj, Ewa, et al.
Publicado: (2016)

Why do we still need participatory technology assessment?
por: Hennen, Leonhard
Publicado: (2012)

Why Do We Need JAK Inhibitors in Systemic Lupus Erythematosus?
por: Richter, Patricia, et al.
Publicado: (2022)

Do we still need to screen our patients?—Orthopaedic scoring based on motion tracking
por: Raab, Dominik, et al.
Publicado: (2023)

A proteinuria cut-off level of 0.7 g/day after 12 months of treatment best predicts long-term renal outcome in lupus nephritis: data from the MAINTAIN Nephritis Trial
por: Tamirou, Farah, et al.
Publicado: (2015)

Management of Lupus Nephritis
por: Tamirou, Farah, et al.
Publicado: (2021)

Lupus Nephritis and Dysbiosis
por: Monticolo, Marta, et al.
Publicado: (2023)

Therapeutic Implications of Renal Biopsies to Detect Proliferative Lupus Nephritis in Patients With Low-Grade Proteinuria
por: Plüß, Marlene, et al.
Publicado: (2020)

Recent advances in the understanding of renal inflammation and fibrosis in lupus nephritis
por: Yung, Susan, et al.
Publicado: (2017)

Cryoballoon ablation: Do we still need real-time recordings?
por: Bisignani, Antonio, et al.
Publicado: (2021)

What do we still need to learn on digitally assessed biomarkers?
por: Acs, Balazs, et al.
Publicado: (2021)

Perspective Technologies of Vaccination: Do We Still Need Old Vaccines?
por: Isaguliants, Maria, et al.
Publicado: (2022)

A Histology-Guided Approach to the Management of Patients with Lupus Nephritis: Are We There Yet?
por: Obrișcă, Bogdan, et al.
Publicado: (2022)

Clinicopathological Correlation in Asian Patients with Biopsy-Proven Lupus Nephritis
por: Satirapoj, Bancha, et al.
Publicado: (2015)

Mast cells in the kidney biopsies of pediatric patients with lupus nephritis
por: Santos, Stéfany Silva, et al.
Publicado: (2020)

Iron Metabolism: An Under Investigated Driver of Renal Pathology in Lupus Nephritis
por: Wlazlo, Ewa, et al.
Publicado: (2021)

Pediatric lupus nephritis
por: Pinheiro, Sergio Veloso Brant, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_mf854g16efv3gg9p2jjkf6jvo5